Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
You'll see more nonalcoholic fatty liver disease (NAFLD).
Up to 100 million Americans have this buildup of fat in the liver. It often goes hand in hand with obesity, dyslipidemia, insulin resistance, and diabetes.
About 20% of patients with NAFLD have nonalcoholic steatohepatitis (NASH)...the more severe form with inflammation and sometimes fibrosis. It's set to be the top reason for liver transplants in the U.S. by 2020.